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P ancreatic ductal adenocarcinoma (PDAC) is cur-rently the 4th leading cause of cancer-related 
deaths worldwide and is estimated to be the 2nd leading 
cause of cancer-related deaths by 2030 [1 , 2].  Although 
surgical resection is mandatory for prolonged survival 
of patients with PDAC,  the tumor is commonly unre-
sectable at initial diagnosis.  Recently,  with the 
advancement of systemic chemotherapy,  many conver-
sion surgeries for initially unresectable,  locally 
advanced pancreatic cancer (URLA-PC) have been 
reported [3 , 4].  Resection and reconstruction of infil-
trated arteries in conversion surgery have been reported 
to be associated with no significant increase in mortality 
and may contribute to improved prognosis in carefully 
selected patients [5 , 6].  Therefore,  it is important to 
develop an effective surgical method for safe arterial 
reconstruction.
Herein,  we present a successful case of conversion 
surgery for URLA-PC involving the nerve plexus 
around the common hepatic artery (CHA) and proper 
hepatic artery (PHA),  using a middle colic artery 
(MCA) transposition technique.
Case Presentation
A 63-year-old man with obstructive jaundice was 
admitted to our institute from a local hospital.  Initial 
laboratory examination showed an extremely high level 
of cancer antigen 19-9 (CA19-9) at 4,016 U/ml.  A 
36-mm tumor without significant contrast effect in the 
pancreatic head was noted on multidetector-row com-
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may provide a new option for hepatic artery reconstruction in such cases.
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puted tomography (CT).  The tumor was in contact with 
the entire length of the CHA,  up to the distal portion of 
the PHA,  with invasion of the nerve plexus around 
them (Fig. 1A).  Fine needle aspiration biopsy using 
endoscopic ultrasound confirmed that the tumor was an 
adenocarcinoma.  Distant metastasis was not observed 
in the patient.  Based on these findings,  the patient was 
diagnosed with URLA-PC.  Written informed consent 
was obtained from the patient for the disclosure of the 
treatment progress and images.
We administered systemic chemotherapy with gem-
citabine plus nab-paclitaxel (gemcitabine 1,000 mg/m2 
and nab-paclitaxel 125 mg/m2 on days 1 , 8,  and 15 
every 4 weeks).  After four treatment cycles,  side effects 
of visual impairment,  possibly due to the systemic che-
motherapy,  occurred.  Thus,  we changed the combina-
tion chemotherapy regimen to modified FORFIRINOX 
(oxaliplatin 85 mg/m2,  irinotecan 150 mg/m2,  and 
leucovorin 200 mg/m2 administered as a bolus,  and 
fluorouracil 2,400 mg/m2 as a 46-hour continuous infu-
sion,  every 2 weeks).  After 12 treatment cycles and 15 
months of chemotherapy,  the CA19-9 levels normal-
ized.  The tumor shrank significantly,  and the effective-
ness of the chemotherapy was judged as “partial 
response”,  based on the Response Evaluation Criteria In 
Solid Tumors (RECIST).  However,  the spread of soft 
tissue density,  suspected to be nerve plexus invasion 
around the CHA and PHA,  persisted (Fig. 1B).  
Therefore,  after a comprehensive review of the patient’s 
treatment progress in a multidisciplinary conference,  
we decided to perform conversion surgery.
After laparotomy,  the peripheral side of the right 
and left hepatic arteries were exposed and dissected 
toward the PHA in the hepatoduodenal ligament.  
Intraoperative pathological examination showed no 
malignancy in the nerve plexus around the distal side of 
the PHA.  Expectedly,  the proximal side of the PHA and 
CHA could not be detached from the stiff tissue around 
it.  The root of the CHA could be exposed and taped,  
without findings of nerve plexus invasion.  Based on 
these findings,  we decided to perform a radical resec-
tion with curative intent; therefore,  subtotal stomach- 
preserving pancreaticoduodenectomy,  combined with 
CHA-PHA,  portal vein (PV) resection,  and D2 lymph 
node dissection was conducted.  For the reconstruction 
of the hepatic artery,  the peripheral portion of the 




















Fig. 1　 Contrast-enhanced CT coronal imaging (A) pre-treatment and (B) post-chemotherapy.  The tumor is in contact with the entire 
length of CHA,  up to the distal portion of PHA,  with the invasion of the nerve plexus around the CHA and PHA.  Despite tumor shrinkage 
with systemic chemotherapy,  the contact with the CHA and PHA and the nerve plexus invasion,  persists.
CT,  computed tomography; T,  tumor; CHA,  common hepatic artery; PHA,  proper hepatic artery; GDA,  gastroduodenal artery; RHA,  
right hepatic artery; LHA,  left hepatic artery; CA,  celiac artery.
MCA was exposed,  mobilized in the transverse meso-
colon,  and dissected towards its root.  The MCA was 
resected at the first bifurcation and transposed upward 
to the hepatoduodenal ligament.  After transecting the 
distal portion of the PHA,  the stump of the PHA and 
the branch patch of the MCA stump were anastomosed 
using an interrupted end-to-end technique,  with 7-0 
prolene (17 stiches) and surgical loupes at 3.5 × magni-
fication (Fig. 2 , 3).  For PV reconstruction,  an internal 
jugular vein graft was interposed between the PV and 
the superior mesenteric vein.  The surgery was com-
pleted after confirming intact perfusion of the trans-
verse colon.  The duration of the operation was 
539 min,  and the amount of blood loss was 740 mL.  
Histopathological examination confirmed that viable 
cancer cells extended into the resected nerve plexus 
surrounding the PHA and CHA (Fig. 4).  The final diag-
nosis was as follows: invasive ductal carcinoma,  TS1 
(20 × 19 mm),  ypT3,  ly1,  v0,  ne3,  ypCH1,  ypDU1,  
ypS1,  ypRP1,  ypPV1,  ypA0,  ypPL1,  ypOO0,  
ypPCM0,  ypDPM0,  ypN0 (0/16),  ypStage IIA,  
according to the Japan Pancreatic Society classification,  
7th edition.  No cancer cells were detected in the surgi-
cal margin (R0).  The efficacy of chemotherapy was 
categorized as Evans grade IIb.
Using Doppler ultrasonography,  we observed that 
the hepatic arterial flow was favorable from postopera-
tive day 1 to 7.  Patency in the PHA-MCA anastomosis 
was confirmed using 3D-CT angiography on postoper-
ative day 15 (Fig. 5).  No major postoperative complica-
tions occurred,  except for surgical site infection of the 
surgical wound,  and the patient was discharged on the 
40th postoperative day.  The patient received S-1 
(80 mg/kg body weight,  administered orally for 4 
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Fig. 3　 Intraoperative image after the reconstruction of the 
hepatic artery and portal vein.
CHA,  common hepatic artery; PHA,  proper hepatic artery; RHA,  
right hepatic artery; LHA,  left hepatic artery; SPA,  splenic 
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Fig. 2　 Graphic illustration of the operation record.  (A) The tumor is in contact with the entire length of the CHA,  up to the distal portion 
of the PHA,  with nerve plexus invasion around them.  (B) The MCA is exposed,  mobilized in the transverse mesocolon,  and dissected 
toward its root.  The MCA is resected at the first bifurcation and transposed upward to the hepatoduodenal ligament.  (C) Anastomosis of 
the PHA and transposed MCA using an end-to-end technique.
CHA,  common hepatic artery; PHA,  proper hepatic artery; RHA,  right hepatic artery; LHA,  left hepatic artery; CA,  celiac artery; SMA,  
superior mesenteric artery; SPA,  splenic artery; MCA,  middle colic artery; PV,  portal vein; SMV,  superior mesenteric vein; IJV,  internal 
jugular vein.
weeks followed by a 2-week rest) as adjuvant chemo-
therapy for 6 months.  He is currently alive,  47 months 
after the initial treatment (31 months after surgery),  
although with local tumor recurrence around the celiac 
artery.
Discussion
Recent advances in chemotherapy have enabled 
“conversion surgery”,  even for unresectable pancreatic 
cancer in patients,  because of a positive response to 
preoperative treatment [7].  Since the 2010s,  there have 
been increasing reports of conversion surgery for 
URLA-PC from high-volume centers [8-9].  According 
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Fig. 4　 (A) Macroscopic examination of the resected specimen showing a hard mass in the pancreatic head.  (B ,C) Histopathological 
examination of hematoxylin and eosin-stained sections reveals generated cancer cells,  extending to the resected nerve tissue around the 
PHA and CHA (arrow).
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Fig. 5　 (A) Preoperative evaluation of the running pattern of the MCA using 3D-CT angiography.  The arrow indicates the MCA.  (B) 
Postoperative evaluation of the hepatic artery by 3D-CT angiography on postoperative day 15.  The arrow indicates the anastomosis of the 
PHA and MCA.
CHA,  common hepatic artery; PHA,  proper hepatic artery; RHA,  right hepatic artery; LHA,  left hepatic artery; SMA,  superior mesenteric 
artery; MCA,  middle colic artery.
to the recent National Comprehensive Cancer Network 
guidelines (2021) [10],  surgical resection for URLA-PC 
is a second-line treatment option for patients with good 
disease response and performance status after initial 
treatment.  Several recent reports indicate that a signifi-
cant decrease in CA19-9 levels after neoadjuvant ther-
apy correlates with good prognosis after pancreatec-
tomy [4 , 11 , 12].  In this case,  conversion surgery after 
chemotherapy with normalized preoperative CA19-9 
levels may have had a positive impact on long-term sur-
vival.
Regarding the surgical procedure,  we performed 
subtotal stomach-preserving pancreaticoduodenec-
tomy,  combined with CHA-PHA resection.  It is very 
difficult to accurately detect viable tumors in the soft 
tissue density area around the great vessels from CT 
findings.  Therefore,  we have adopted this procedure 
with arterial resection to obtain radical resection,  even 
when cancer cells remain in the nerve plexus around the 
CHA/PHA.  Total pancreatectomy could be an alterna-
tive in this case.  However,  we usually attempt to avoid 
total pancreatectomy because it results in poor glycemic 
control and malnutrition,  which might lead to a low 
completion rate of adjuvant therapy.  In a case of posi-
tive surgical margins,  based on intraoperative patho-
logical findings during pancreatoduodenectomy,  total 
pancreatectomy with celiac artery resection can be 
selected to achieve curative resection.
Conversion surgery occasionally requires simulta-
neous vascular resection and reconstruction; however,  
for locally advanced pancreatic cancer,  combined arte-
rial resection remains debatable because of the associ-
ated high rates of severe complications [13].  Arterial 
reconstruction is commonly required for patients 
undergoing pancreaticoduodenectomy with hepatic 
artery resection,  except when the patient presents with 
aberrant hepatic arteries [14].  The crucial point is to 
ensure hepatic perfusion while achieving curative resec-
tion [15 , 16].  Therefore,  sufficient knowledge of arterial 
reconstruction during pancreaticoduodenectomy with 
hepatic artery resection is essential.  Several methods of 
hepatic artery reconstruction,  such as CHA-PHA direct 
anastomosis,  CHA-PHA anastomosis with a vein graft 
interposition,  splenic artery-PHA anastomosis,  and left 
gastric artery-PHA anastomosis,  have been described 
previously [17-21].
In the present case,  we decided to use MCA for 
hepatic artery reconstruction.  From a technical view-
point,  the most important aspect in this reconstruction 
is the careful dissection of the nerve plexus around the 
root of the MCA to avoid tension when the MCA is 
transposed upward for anastomosis.  This is the first 
report,  to the best of our knowledge,  of anastomosis 
between the PHA and MCA during pancreatoduo-
denectomy.  MCA was used for the following reasons.  
First,  since this pancreatic head carcinoma was pre-
sumed to have originated from the dorsal primordium 
of the pancreas,  there was a greater possibility of local 
recurrence in the retroperitoneal tissue around the 
celiac artery than around the superior mesenteric artery.  
Moreover,  we considered that if the left gastric artery or 
the splenic artery was used as the reconstructive vessel,  
hepatic artery blood flow might be obstructed by the 
recurrent lesion.  Actually,  local recurrence was 
occurred around the celiac artery 18 months after con-
version surgery.  Next,  the MCA would be exposed 
easily in the transverse mesocolon under the same field 
of view during pancreatoduodenectomy,  and the stump 
of the MCA would be close to that of the PHA when it is 
transported upwards to the hepatoduodenal ligament.  
Finally,  when the difference between PHA and MCA 
was identified,  the diameter of the stump of the MCA 
could be adjusted using a branch patch with the bifur-
cation of the MCA (Fig. 2).  The reconstructed MCA-
PHA anastomosis was patent,  31 months after conver-
sion surgery,  despite local recurrence around the celiac 
artery.
Conclusion
In conclusion,  the described MCA transposition 
technique for reconstruct the hepatic artery during 
pancreatoduodenectomy in patients with URLA-PC 
could be a useful surgical option for hepatic artery 
reconstruction.  Further studies are required to deter-
mine the efficacy of this technique.
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